Results are earmarked for July, so we are starting to get very close now!
Has anyone received any update on the timing of this information or even confirmation of the previous stages?
If this is all running to plan and on schedule, its going to get very interesting for VHL!
Current market cap is approximately $12m. With a share of the proceeds from the Novartis option expected early next financial year (July-Aug?), solid results from the Vir201 trials (July?), and the potential for further external funding from big corporate to be announced, there is large scope to significantly grow the company's value over these coming months. This is a pivotal period in the company's development.
Of course if it doesn't fire who knows what state we'll be in (50% down?) but the upside to this baby is still looking huge.
Results are earmarked for July, so we are starting to get very...
Add to My Watchlist
What is My Watchlist?
